12913 studies found for:    Canada
Show Display Options
Rank Status Study
1 Completed A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Aleglitazar;   Drug: Placebo
2 Active, not recruiting
Has Results
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Acetylsalicylic acid
3 Completed Combination Chemotherapy in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: dexamethasone;   Drug: melphalan;   Drug: prednisone
4 Completed
Has Results
Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients
Conditions: Critical Illness;   Sepsis;   Multiple Organ Failure
Interventions: Other: Glutamine;   Other: Antioxidants;   Other: Glutamine + Antioxidants;   Other: Placebo
5 Active, not recruiting A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)
Condition: Rheumatoid Arthritis
Intervention:
6 Recruiting A Study of Kadcyla (Trastuzumab Emtansine) Plus Perjeta (Pertuzumab) Following Anthracyclines in Comparison With Herceptin (Trastuzumab) Plus Perjeta and a Taxane Following Anthracyclines as Adjuvant Therapy in Patients With Operable HER2-Positive Primary Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anthracycline-based chemotherapy;   Drug: pertuzumab [Perjeta];   Drug: taxane;   Drug: trastuzumab [Herceptin];   Drug: trastuzumab emtansine [Kadcyla]
7 Completed
Has Results
Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement
Conditions: Arthroplasty, Replacement, Knee;   Thromboembolism
Interventions: Drug: Dabigatran Dose 1 - day 2 to completion;   Drug: Dabigatran Dose 1 - day 1;   Drug: Dabigatran Dose 2 - day 2 to completion;   Drug: Dabigatran Dose 2 - day 1;   Drug: Enoxaparin
8 Completed Flavopiridol in Treating Patients With Metastatic Malignant Melanoma
Condition: Melanoma (Skin)
Intervention: Drug: alvocidib
9 Completed Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: cetuximab;   Drug: brivanib alaninate
10 Completed Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration
Condition: Hypercholesterolemia
Intervention: Drug: atorvastatin
11 Recruiting Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   High Risk for Cardiovascular Event
Interventions: Drug: Dapagliflozin 10 mg;   Drug: Placebo tablet
12 Completed TOP: Trial of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: ALX1-11
13 Terminated
Has Results
JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events
Condition: Elevated High-sensitivity C-Reactive Protein (hsCRP)
Interventions: Drug: Rosuvastatin;   Other: Placebo
14 Completed Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer;   Skin Reactions Secondary to Radiation Therapy
Interventions: Drug: Biafine cream;   Procedure: quality-of-life assessment;   Radiation: radiation therapy
15 Recruiting Evaluation of Diet and Exercise in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention:
16 Active, not recruiting
Has Results
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 10773;   Drug: Glimepiride;   Drug: Placebo
17 Not yet recruiting Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
Condition: Chronic Heart Failure With Reduced Ejection Fraction.
Intervention: Drug: LCZ696
18 Active, not recruiting Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA
Condition: Rheumatoid Arthritis
Intervention:
19 Active, not recruiting Open Label Study of Long Term Evaluation Against LDL-C Trial
Condition: Hypercholesterolemia
Interventions: Biological: Evolocumab (AMG 145) and standard of care;   Other: Standard of care
20 Completed
Has Results
An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.
Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years